Skip to content

MRI-based Habitat Analysis to Assess Pathologic Response and Disease-Free Survival After Preoperative Neoadjuvant Therapy for Triple-Negative Breast Cancer

MRI-based Habitat Analysis to Assess Pathologic Response and Disease-Free Survival After Preoperative Neoadjuvant Therapy for Triple-Negative Breast Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106525
Enrollment
Unknown
Registered
2025-07-25
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Triple-Negative Breast Cancer

Interventions

Relapse-free group:None
Pathologic complete response group,:None
non-pathologic complete response group:None
Group with relapse:None

Sponsors

Chongqing University Three Gorges Hospital(Chongqing Three Gorges Central Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age greater than or equal to 18 years, female; 2.Pathologically confirmed triple-negative breast cancer by puncture or surgical biopsy; 3.MRI completed prior to puncture; 4.Clinical indications for NAT were present, none of them had received any treatment prior to enrollment, and blood, electrocardiogram, and liver and renal function tests were shown to be normal at the time of admission to the hospital.

Exclusion criteria

Exclusion criteria: 1.Exclude specific types of breast cancer such as secretory carcinoma and adenoid cystic carcinoma from triple-negative breast cancer. 2.Excluding patients with other malignant neoplastic diseases or other important functional organ pathologies; 3.Exclusion of patients with contraindications to MRI; 4.Exclusion of patients with incomplete clinical information on NAT and pathologic information.

Design outcomes

Primary

MeasureTime frame
Surgical pathology results;Post-treatment relapse;

Countries

China

Contacts

Public ContactYiming Yao

Chongqing University Three Gorges Hospital

171178616@qq.com+86 18118218839

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026